CD274 and neoplasm: The proportion of patients with estrogen receptor-positive MBC was 70% in NIMBUS and 43% in TAPUR; only 14% of patients included in NIMBUS had PD-L1-positive tumors (a tumor presenting a CPS score ≥ 10 was classified as PD-L1 positive), while this information is unknown in TAPUR.